GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company was founded by David P. Summers in 2011 and is headquartered in Richland, WA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of GlobeStar Therapeutics Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. GlobeStar Therapeutics Corp market cap is $1,200.00.
What is the 52-week high for GlobeStar Therapeutics Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GlobeStar Therapeutics Corp 52 week high is $0.0007 as of October 10, 2025.
What is the 52-week low for GlobeStar Therapeutics Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GlobeStar Therapeutics Corp 52 week low is $0.00 as of October 10, 2025.
What is the 50-day moving average of GlobeStar Therapeutics Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GlobeStar Therapeutics Corp 50-day moving average is $0.00.
